Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Plasma Exchange with Albumin in Alzheimer's Disease
NCT00742417Phase 2Completed
- Sponsor
- Grifols
- Start
- Jul 2007
- Primary completion
- Feb 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 2
01
Overview
Phase 2, randomised, double-blind trial of human albumin in Alzheimer's disease (AD) (2 arms), sponsored by Grifols. Primary endpoint: Change From Baseline in Aβ1-42 Cerebrospinal Fluid Levels at Week 44. Started Jul 2007; status: completed.
02
Drugs
human albumin
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT00742417.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00742417.